MedTrace Logo

Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease

NCT05203484 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2022-08-19

No results posted yet for this study

Summary

VT ablation is a frequently performed intervention in patients with symptomatic ventricular tachycardia, electrical storm due to monomorphic VT and appropriate ICD shocks, primarily aiming at reducing the burden of complaints, and ICD shocks. The recommendations for its use were described in the ESC guideline for ventricular arrhythmias and the prevention of sudden cardiac death. To visualize the arrhythmogenic substrate leading to ventricular tachycardia complex mapping techniques are currently used in clinical routine, including conventional Point-by-Point mapping or Multielectrode Mapping. The latter is associated with shorter Mapping and overall procedure times, while maintaining the same primary endpoint of the procedure itself. The aim of this trial is to validate, whether the reduction of mapping and procedure time is associated with a comparable long-term outcome compared with conventional Point-by-Point mapping.

Conditions

  • Ventricular Tachycardia

Interventions

DEVICE

Multielecotrde Mapping

Multielectrode Mapping with Pentaray/Octaray

DEVICE

Point-by-point mapping

Point-by-point mapping with QDot

Sponsors & Collaborators

  • Helios Health Institute GmbH

    lead OTHER

Principal Investigators

  • Aarsh Arya, PD · leipzig heart centre

  • Gerhard Hindricks, Prof. Dr. · leipzig heart centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-07-30
Completion
2024-07-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05203484 on ClinicalTrials.gov